Vestal Point Capital, LP 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 2:35 pm Purchase |
2024-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Vestal Point Capital, LP | 11,500,000 9.900% |
10,355,000 (+904.37%) |
Filing |
| 2024-11-14 12:00 pm Sale |
2024-09-30 | 13G | Applied Therapeutics, Inc. APLT |
Vestal Point Capital, LP | 1,145,000 1.000% |
-3,010,000 (-72.44%) |
Filing |
| 2024-02-13 4:34 pm Purchase |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Vestal Point Capital, LP | 4,155,000 5.400% |
4,155,000 (New Position) |
Filing |